AU1059095A - Treatment of viral disease with cd40l peptide - Google Patents

Treatment of viral disease with cd40l peptide

Info

Publication number
AU1059095A
AU1059095A AU10590/95A AU1059095A AU1059095A AU 1059095 A AU1059095 A AU 1059095A AU 10590/95 A AU10590/95 A AU 10590/95A AU 1059095 A AU1059095 A AU 1059095A AU 1059095 A AU1059095 A AU 1059095A
Authority
AU
Australia
Prior art keywords
treatment
viral disease
cd40l peptide
cd40l
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10590/95A
Inventor
Ian Allister Ramshaw
Janet Caroline Ruby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian National University
Original Assignee
Australian National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Australian National University filed Critical Australian National University
Publication of AU1059095A publication Critical patent/AU1059095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU10590/95A 1993-11-24 1994-11-23 Treatment of viral disease with cd40l peptide Abandoned AU1059095A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM258793 1993-11-24
PCT/AU1994/000722 WO1995014487A1 (en) 1993-11-24 1994-11-23 Treatment of viral disease with cd40l peptide

Publications (1)

Publication Number Publication Date
AU1059095A true AU1059095A (en) 1995-06-13

Family

ID=3777378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10590/95A Abandoned AU1059095A (en) 1993-11-24 1994-11-23 Treatment of viral disease with cd40l peptide

Country Status (2)

Country Link
AU (1) AU1059095A (en)
WO (1) WO1995014487A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
AU781104B2 (en) * 1996-12-09 2005-05-05 Regents Of The University Of California, The Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
AU2004199A (en) * 1997-12-19 1999-07-12 Immunex Corporation Method for reducing susceptibility to hiv infection
KR100743894B1 (en) * 1998-02-27 2007-07-30 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Vaccines, Immunotherapeutics and Methods for Using the Same
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en) 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
KR101460551B1 (en) 2006-09-18 2014-11-18 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 Compositions and methods of enhancing immune responses
US9125854B2 (en) 2007-10-30 2015-09-08 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
CA3051748C (en) 2007-11-01 2022-07-12 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria
PL2525817T3 (en) 2010-01-21 2018-01-31 Univ Arkansas Vaccine vectors and methods of enhancing immune responses
UA113496C2 (en) 2010-06-09 2017-02-10 VECTOR AND METHOD OF INCREASING INFECTION RESULTING TO CAMPYLOBACTER
JP6532407B2 (en) 2013-02-14 2019-06-19 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー Compositions and methods for enhancing the immune response to Eimeria or limiting Eimeria infection
MX2015012855A (en) 2013-03-15 2016-07-21 Univ Arkansas Compositions and methods of enhancing immune responses to enteric pathogens.
TW202224701A (en) 2016-05-03 2022-07-01 阿肯色州大學董事會 Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233402T3 (en) * 1991-10-25 2009-06-25 Immunex Corp., Seattle NEW CYTOKINE
IL104684A0 (en) * 1992-02-14 1993-06-10 Bristol Myers Squibb Co The cd40cr receptor and ligands therefor
DE4322330A1 (en) * 1992-08-31 1994-03-03 Behringwerke Ag Use of the IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases as well as fungal infections
AU5098493A (en) * 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
US5540926A (en) * 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation

Also Published As

Publication number Publication date
WO1995014487A1 (en) 1995-06-01

Similar Documents

Publication Publication Date Title
AU6360394A (en) Vasonatrin peptide and analogs thereof
AU7043394A (en) Association peptides
AU7867994A (en) Hemofiltration of mediator-related diseases
AU3688393A (en) Surgical fastener
AU7516694A (en) Biotinylation of proteins
AU4230196A (en) Treatment of pancreatic tumors with peptide yy and analogs thereof
AU3802493A (en) Surgical endoclip
AU4944093A (en) Osteosynthesis aid
AU4514193A (en) Bone formation-inducing protein
AU4048295A (en) Peptide medicaments for the treatment of disease
AU1059095A (en) Treatment of viral disease with cd40l peptide
AU4463996A (en) Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU6774294A (en) Methods of preventing viral replication
AU5681094A (en) Protein hydrolysate derived from mucosal tissue
AU3414689A (en) Therapeutic peptides
AU5380194A (en) Dual fixation prosthesis
AU6428890A (en) Therapeutic peptides and proteins
AU4775693A (en) Peptide medicaments for treating disease
EP0689455A4 (en) Therapeutic strategies for immunoinfective cluster virus infections
AU5758594A (en) Treatment of viral infections
AU1192892A (en) Pharmaceutical preparation of antistress, stress-preventive and nootropic action
AU4628993A (en) Physiologically active peptide composition
AU6856194A (en) Vaginal preparation containing physiologically active peptide
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
AU3187893A (en) Disposable internal electrode